Achondroplasia is a genetic skeletal condition caused by FGFR3 pathogenic variants. Infigratinib, an oral FGFR1–3 tyrosine kinase inhibitor, down-regulates key pathways in the pathogenesis of ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
Gurugram: As part of an ongoing drive, the enforcement wing of the Department of Town and Country Planning (DTCP) on Friday sealed seven residential properties on the Nathupur Road in DLF Phase-3 for ...
After being left unprotected in Phase 1, Julia Gosling rejected an FPO in Phase 2 to remain a part of the Seattle Torrent's core. Troy Parla / Getty Images The third phase of the PWHL’s multi-step ...
COLORADO (KOAA) — Colorado Governor Jared Polis has activated Phase 3 of the state's Drought Response Plan and issued a statewide Drought Emergency declaration. The declaration and plan activation are ...
The U.S. Space Force is requesting industry input to identify launch providers that could support up to 25 high-priority National Security Space Launch Phase 3 missions scheduled for fiscal years 2027 ...
A phase 3 study of Gossamer Bio’s seralutinib in pulmonary arterial hypertension (PAH) has missed its primary endpoint, triggering a 77% crash in the biotech’s share price. The company has paused ...
Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.
Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...
Both dosage regimens of amlitelimab were associated with statistically significant improvements in skin clearance and disease severity vs placebo in the US estimand. Topline data were announced from ...
Zasocitinib showed superiority over placebo in phase 3 trials, achieving rapid and sustained skin clearance in plaque psoriasis. The trials demonstrated a favorable safety profile, with common adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results